Research ArticleCancer therapy

MEK inhibitor trametinib does not prevent the growth of anaplastic lymphoma kinase (ALK)–addicted neuroblastomas

See allHide authors and affiliations

Science Signaling  28 Nov 2017:
Vol. 10, Issue 507, eaam7550
DOI: 10.1126/scisignal.aam7550

Article Information

vol. 10 no. 507

PubMed: 
Published By: 
Print ISSN: 
Online ISSN: 
History: 
  • Received January 11, 2017
  • Accepted October 31, 2017
  • .

Author Information

Altmetric

Article usage

Article usage: November 2017 to April 2020

AbstractFullPdf
Nov 2017172754110
Dec 2017387965146
Jan 20182311634
Feb 20181971528
Mar 20181311535
Apr 20181072124
May 2018120920
Jun 2018831212
Jul 2018781613
Aug 2018743315
Sep 201848198
Oct 201856316
Nov 2018725223
Dec 2018010245
Jan 2019311840
Feb 201919037
Mar 201967131
Apr 201937935
May 201968040
Jun 201938626
Jul 2019128021
Aug 201967425
Sep 2019148125
Oct 201967623
Nov 2019105613
Dec 201974919
Jan 202017237
Feb 202016621
Mar 202026730
Apr 2020032

Stay Connected to Science Signaling


Editor's Blog

Navigate This Article